180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 296 | 265 | 173 | 140 | 148 |
| Operating Income | -296 | -265 | -173 | -140 | -148 |
| Other Income | 356 | 592 | 633 | 547 | 486 |
| Pre-tax Income | 60 | 327 | 460 | 407 | 338 |
| Income Tax | 70 | 96 | 123 | 87 | 126 |
| Net Income Continuous | -11 | 232 | 336 | 320 | 211 |
| Net Income | $-11 | $232 | $336 | $320 | $211 |
| EPS Basic Total Ops | 0.00 | 22.81 | 30.42 | 30.42 | 19.01 |
| EPS Basic Continuous Ops | -0.97 | 21.48 | 30.89 | 29.12 | 19.19 |
| EPS Diluted Total Ops | 0.00 | 7.60 | 11.41 | 7.60 | 3.80 |
| EPS Diluted Continuous Ops | -0.97 | 6.57 | 8.59 | 8.17 | 5.40 |
| EBITDA(a) | $-296 | $-265 | $-173 | $-140 | $-148 |